Research Antibodies Market, by Product Type (Primary Antibodies, Secondary Antibodies, Reagents, Consumables), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mouse, Rabbit, Goat, Others (Guinea Pigs, Rat, etc.))

Research Antibodies Market, by Product Type (Primary Antibodies, Secondary Antibodies, Reagents, Consumables), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mouse, Rabbit, Goat, Others (Guinea Pigs, Rat, etc.)), by Application (Western Blotting, ELISA, Flow Cytometry, Immunocytochemistry (ICC)/ Immunofluorescence (IF), Immunohistochemistry (IHC), Others), by End User (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

The small proteins known as antibodies, which are an essential component of immune system's reaction to diseases, are helpful in biomedical research. For decades, researchers have been developing antibodies to fight and understand viruses like Covid-19 and many common infectious disorders. The majority of antibodies used in research are referred to as "animal-derived" and are obtained from animals. A small quantity of the desired foreign antigen is injected into an animal. This triggers the immune system to generate antibodies in defense. These are then collected for use in research, either from the spleen or the blood.

Market Dynamics

Increasing collaborations and partnerships in market players is expected to witness significant growth in forecast period. For instance, in March 2022, Sanofi, a French multinational pharmaceutical and healthcare company and Seagen Inc., an American biotechnology company announced an exclusive collaboration agreement to design, develop, and market antibody-drug conjugates (ADCs) for up to three cancer targets. The collaboration will make use of the exclusive monoclonal antibody (mAb) technology from Sanofi and the exclusive ADC technology from Seagen. Sanofi is now working on an ADC, which is an antibody designed to carry powerful anti-cancer medications to tumor cells expressing a certain protein.

Increasing product launches by market players are expected to drive growth of the global research antibodies market over the forecast period. For instance, in April 2019, ImmunoPrecise, a full-service, therapeutic antibody discovery company launched DeepDisplay, Antibody Discovery Platform with an unknown U.S. based Pharma Company. In contrast to conventional technologies, DeepDisplay uses a transgenic animal immunization combined with phage display antibody selection to deliver the most therapeutically-relevant antibodies in the shortest amount of time with the highest chances of success.

Increasing product approvals are expected to drive growth of market over the forecast period. For instance, in April 2021, Gilead Sciences Inc., an American biopharmaceutical company announced that Trodelvy (sacituzumab govitecan-hziy), for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, has received full approval from the U.S. Food and Drug Administration (FDA). Trodelvy (sacituzumab govitecan-hziy) is an antibody–drug conjugate that combines a humanized monoclonal antibody.

Key features of the study:

• This report provides an in-depth analysis of the global research antibodies market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global research antibodies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals and Abcam plc.
• Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The global research antibodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global research antibodies market

Detailed Segmentation:

• Global Research Antibodies Market, By Product Type:
• Primary Antibodies
• Secondary Antibodies
• Reagents
• Consumables
• Global Research Antibodies Market, By Form:
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Global Research Antibodies Market, By Source:
• Mouse
• Rabbit
• Goat
• Others (Guinea Pigs, Rat etc.)
• Global Research Antibodies Market, By Application:
• Western Blotting
• ELISA
• Flow Cytometry
• Immunocytochemistry (ICC)/ Immunofluorescence (IF)
• Immunohistochemistry (IHC)
• Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
• Global Research Antibodies Market, By End User:
• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Global Research Antibodies Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Thermo Fisher Scientific Inc.*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Bio-rad Laboratories
• Lonza Group
• Merck Millipore
• Cell Signalling Technology Inc.
• F.Hoffmann La Roche Ltd.
• Novartis AG
• Takeda Pharmaceutical Company
• Agilent Technologies
• Danaher Corporation
• BioLegend Inc.
• Illumina
• Phoenix Pharmaceuticals
• Abcam plc.

“*” marked represents similar segmentation in other categories in the respective section.